Tci Wealth Advisors, Inc. Cerus Corp Transaction History

Tci Wealth Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$3.43 - $5.83 $2,816 - $4,786	821 New	821 $3,000
Q1 2022 Apr 29, 2022	SELL	$4.81 - $6.99 $2,770 - $4,026	-576 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$4.79 - $6.68 $1,173 - $1,636	245 Added 74.02%	576 $4,000
Q2 2021 Aug 02, 2021	BUY	$5.35 - $6.35 $1,770 - $2,101	331 New	331 $2,000
Q2 2019 Jul 23, 2019	SELL	$4.51 - $6.6 $4,803 - $7,029	-1,065 Closed	0 $0
Q1 2019 Apr 11, 2019	SELL	$5.16 - $6.85 $4,587 - $6,089	-889 Reduced 45.5%	1,065 $7,000
Q3 2018 Nov 02, 2018	SELL	$6.89 - $7.78 $3,796 - $4,286	-551 Reduced 22.0%	1,954 $14,000
Q2 2018 Jul 27, 2018	SELL	$5.19 - $7.25 $8,537 - $11,926	-1,645 Reduced 39.64%	2,505 $17,000
Q2 2017 Aug 10, 2017	BUY	N/A	4,150	4,150 $10,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $322M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.